Results 71 to 80 of about 139 (105)

ALKBH1 rs2267755 C>T polymorphism decreases neuroblastoma risk in Chinese children

open access: yesJournal of Cancer
Neuroblastoma is a highly malignant extracranial solid tumor in pediatrics. ALKBH1 as a recently discovered DNA N6-methyldeoxyadenosine (6mA) demethylase closely links to tumorigenesis. Whether the ALKBH1 polymorphism contributes to neuroblastoma risk remains unclear.
Zhang, Xinxin   +6 more
openaire   +2 more sources

ALKBH1-mediated N6-methyladenosine methylation of TRAF1 promotes osteosarcoma proliferation and metastasis

open access: yesAmerican Journal of Cancer Research
Osteosarcoma (OS) is a highly malignant bone tumor with poor prognosis and limited therapeutic options. Recent studies have highlighted the critical role of RNA modifications, particularly N6-methyladenosine (m6A) methylation, in cancer progression.
Zhichao, Wang   +3 more
openaire   +2 more sources

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Structural basis of nucleic acid recognition and 6mA demethylation by human ALKBH1 [PDF]

open access: yesCell Research, 2020
Li-Fei Tian   +7 more
openaire   +2 more sources

m1A and m6A RNA Methylations as Druggable Targets in Cancer

open access: yesPharmaceuticals
Epitranscriptomic modifications, particularly RNA methylations, have emerged as regulators of gene expression, with their dysregulation acting as a key factor in tumorigenesis and metastatic progression.
Yasemin Gazaloğlu   +2 more
doaj   +1 more source

Research progress of N1-methyladenosine RNA modification in cancer

open access: yesCell Communication and Signaling
N1-methyladenosine (m1A) is a post-transcriptionally modified RNA molecule that plays a pivotal role in the regulation of various biological functions and activities. Especially in cancer cell invasion, proliferation and cell cycle regulation.
Yafeng Liu   +5 more
doaj   +1 more source

Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance against cellular stress in bladder cancer

open access: yesFrontiers in Oncology
BackgroundBladder cancer (BLCA) is a common and deadly disease that results in a reduced quality of life for the patients and a significant economic burden on society. A better understanding of tumorigenesis is needed to improve clinical outcomes. Recent
Ida Monshaugen   +15 more
doaj   +1 more source

A novel disulfidptosis-related mRNA signature predicts prognosis and therapeutic response in lung squamous cell carcinoma

open access: yesBMC Pulmonary Medicine
Background Lung squamous cell carcinoma (LUSC) remains an aggressive malignancy with limited therapeutic options and poor prognosis. Recent studies have identified disulfidptosis as a novel form of metabolic stress-induced cell death, but its clinical ...
Wei Bai   +11 more
doaj   +1 more source

ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation

open access: yesCancer Discovery
Abstract Cancer cells utilize codon-biased translation to fuel tumorigenesis and drug resistance; however, underlying mechanisms remain poorly understood. In this study, we show that ALKBH1 is overexpressed in acute myeloid leukemia (AML) and essential for leukemia stem cell/leukemia ...
Chao Shen   +32 more
openaire   +3 more sources

In vivo characterization of the mammalian AlkB homologues ALKBH1 and ALKBH4

open access: yes, 2014
The E.coli DNA repair enzyme AlkB acts by hydroxylating methyl lesions in DNA, such as 1-methylAdenine (1meA) and 3-methylCytosine (3meC), which leads to spontaneous loss of the hydroxymethyl group and recovery of the correct base. Nine different mammalian AlkB homologues have been identified.
openaire   +4 more sources

Home - About - Disclaimer - Privacy